Pathology
 |
|
16 december 2018 21:01:47 |
| HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia (Leukemia) |
|
Tweet |
| 79 viewsCategory: Pathology |
 The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia (Leukemia)Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome (Leukemia) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
